The CUBN gene helps your gut absorb vitamin B12 from food and helps your kidneys keep useful proteins from leaking into urine. If it does not work properly, you may develop low vitamin B12, which can lead to anemia, tiredness, poor growth, and nerve symptoms, and some people also have protein in the urine. Many variants in this gene have little effect, while certain inherited variants can cause Imerslund-Gräsbeck syndrome, a condition marked by vitamin B12 deficiency. The CUBN gene is mainly known in medicine rather than popular culture.
What is a gene?
Genes are stretches of DNA that give your cells instructions for making molecules or directing processes in the body. Some genes carry the information needed to make proteins, the parts of cells that do much of the work. Others mainly regulate when certain processes happen, where they happen, and how active they are. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, and medications. If you want to look at this topic more closely, you can read more in the LearnHub.
Overview
CUBNGene function
What if the gene works
The CUBN gene helps your small intestine absorb vitamin B12 from food. It also supports the kidneys in taking back useful proteins so they are not lost in urine.
Risk
What if the gene does not work
Variants in the CUBN gene can reduce vitamin B12 absorption and cause inherited vitamin B12 deficiency, often with protein in the urine. Milder or more severe variants may affect when symptoms start and how marked these features are.
Treatment
What does that mean for your treatment
With a pathogenic variant in the CUBN gene, treatment usually relies on lifelong vitamin B12 replacement, often intramuscular hydroxocobalamin or cyanocobalamin rather than standard oral doses. This can normalize blood counts and help protect the nervous system, although associated low grade protein in the urine may remain.
Conditions associated with CUBN
Gene function
What if the gene works
CUBN helps your body hold on to important nutrients and proteins during everyday digestion and kidney filtering. It is especially active in the small intestine and kidneys. When it works normally, it supports vitamin B12 absorption from food and helps useful proteins return to the body instead of passing out in urine.
In the small intestine, the CUBN gene helps cells take in vitamin B12 after it has attached to intrinsic factor (a stomach protein that carries B12). This supports normal blood cell making and nerve health.
In the kidneys, the CUBN gene helps tubule cells reabsorb small proteins that the body still needs. This helps useful carriers, vitamins, and other blood proteins stay in the body rather than leaving in urine.
The CUBN gene makes part of a receptor, a cell surface catcher that recognizes certain nutrients and proteins. With helper proteins, it helps cells pull these materials inside so they can be reused.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These changes are common and are part of normal human diversity, such as differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene functions more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the CUBN gene can change cubilin's shape or reduce how much reaches the cell surface, weakening uptake of vitamin B12 bound to intrinsic factor and proteins filtered by the kidney. This shows how CUBN gene variants affect protein function: some partly reduce activity, while more disruptive variants can block partner binding or stop the protein being made. That spectrum can lead to milder or more pronounced effects.
How variants are linked to conditions
Pathogenic variants in the CUBN gene can cause Imerslund-Gräsbeck syndrome, an inherited condition marked by vitamin B12 deficiency that often leads to megaloblastic anemia. Many people also have persistent protein in the urine, although kidney function can remain normal. Some other CUBN gene variants have been linked to albuminuria or proteinuria risk in population studies, but these common findings do not by themselves confirm disease.
A variant is not necessarily a diagnosis
Genetic variants are common in the general population and are a normal feature of human biology. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors contribute. In some situations, though, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For CUBN-related conditions, risk is mostly set by the gene change itself, especially when a child inherits altered copies from both parents. Family history and whether a partner also carries a CUBN variant can change the chance for children. There is not enough evidence to say that diet, exercise, or other lifestyle steps lower this genetic risk.
Inheritance of CUBN variants
For the best established CUBN gene conditions, the CUBN gene inheritance pattern is autosomal recessive. This means a person usually inherits one altered copy from each parent, and the parents are often healthy carriers. When both parents carry a CUBN gene variant, each pregnancy has a 25% chance of a child with the condition, a 50% chance of a child who is also a carrier, and a 25% chance of a child with two working copies. Sons and daughters are affected equally.
What does my CUBN result mean for my family?
For families with a disease-causing CUBN result linked to a recognized condition, the usual pattern is recessive, which means close relatives may be carriers even if they feel well. Brothers and sisters could also have the condition or be carriers, so the result can matter beyond one person. This is most clearly established for the inherited form of vitamin B12 absorption problems linked to CUBN.
Genetic information
Genetic testing
How you find out about variants
To look for changes in the CUBN gene, CUBN genetic testing uses a blood sample, saliva, or cheek swab to read the DNA code. Results may identify a specific variant, show no relevant variant, or find a change whose meaning is not yet clear.
When should I consider getting a genetic test?
Consider testing for changes in the CUBN gene if there is unexplained vitamin B12 deficiency, especially from childhood, with anemia, tiredness, poor growth, or protein in the urine. Testing can also help if this pattern runs in your family or if a doctor suspects an inherited problem absorbing vitamin B12.
A genetic result is only one part of your health story
Genetic test results can be informative, but how much they reveal varies by the condition and the specific type of variant. Many other factors also shape how the body works over time, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it into tissues, or responds to it at its target, so the same treatment may work better for one person than for another. This is a common part of human biology and can influence how much benefit someone gets from a medicine or how sensitive they are to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect a person’s response to medications. By looking at relationships between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medicines, genes can influence how strongly a drug works or how the body processes it. This information can support more informed and personalized treatment decisions. To explore this topic further, you can learn more in the LearnHub.
Drugs influenced by the CUBN gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication response in routine care. If you have side effects, a medicine is not working as expected, or you have questions about treatment, talk with your doctor or pharmacist.
History
Throughout history, clinicians described families in which children had trouble absorbing vitamin B12 and often had protein in the urine, a pattern later named Imerslund-Gräsbeck syndrome. In the 1960s, these reports helped establish the condition as an inherited one rather than a nutritional problem alone. From these first observations, research expanded steadily, and scientists later linked the syndrome to a receptor in the intestine and kidney called cubilin. In the 1990s, the CUBN gene was identified as the gene that provides instructions for this protein, helping connect the clinical picture to its genetic cause. Further studies then showed that variants in the CUBN gene can also explain milder or different patterns of protein loss in urine. This history made the CUBN gene an important part of understanding inherited vitamin B12 malabsorption.